NCT04087187 A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718 Status COMPLETED Phase PHASE1
NCT04087174 A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE1
NCT04083365 Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer Status UNKNOWN Phase PHASE2
NCT04078126 Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing. Status COMPLETED Phase PHASE3
NCT04076943 Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia Status COMPLETED Phase PHASE2
NCT04076579 Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma Status COMPLETED Phase PHASE2
NCT04076540 A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04075292 Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04073160 TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer Status WITHDRAWN Phase PHASE1
NCT04072562 A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT04072523 An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes Patients Status COMPLETED Phase N/A
NCT04069234 Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. Status WITHDRAWN Phase PHASE3
NCT04068168 Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS) Status COMPLETED Phase N/A
NCT04065269 ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04064190 Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition Status WITHDRAWN Phase PHASE2
NCT04063930 The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia Status UNKNOWN Phase PHASE4
NCT04062708 CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04055168 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects Status TERMINATED Phase PHASE1